US Activist Hedge Fund Institutional SEC 13D 13G — July 20, 2026

20-07-2026

EcoR1 Capital, LLC and related entities filed a Schedule 13G disclosing a 5.8% beneficial ownership stake in Alto Neuroscience, Inc. as of July 13, 2026. The filing reports 2,232,000 shares held by EcoR1 Capital and its control person Oleg Nodelman, with EcoR1 Capital Fund Qualified, L.P. holding 2,065,935 shares (5.3%). The filing is a passive investment disclosure with no intent to change or influence control of the company.

• · The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
• · EcoR1 Capital, LLC serves as the general partner and investment adviser of investment funds, including the Qualified Fund.
• · Oleg Nodelman is the control person of EcoR1 Capital, LLC.
• · The percentage ownership is calculated based on 38,829,167 shares outstanding following the closing of the issuer's offering reported in the Prospectus filed on July 14, 2026.
• · Each reporting person disclaims beneficial ownership except to the extent of their pecuniary interest.
• · The Qualified Fund expressly disclaims membership in a group and being a beneficial owner under Rule 13d-3.

20-07-2026

Atlas Capital Resources (A9) LP and affiliated entities, collectively owning 23.1% of Vulcan Infrastructure & Power Inc. (f/k/a Greenidge Generation Holdings Inc.), filed Amendment No. 5 to their Schedule 13D on July 20, 2026. The filing discloses a private placement agreement dated July 19, 2026, under which an Atlas affiliate will purchase 2,923,976 shares of Class A Common Stock at $1.71 per share for an aggregate purchase price of $5,000,000. The transaction includes board reconstitution rights and other governance provisions, but the filing does not provide any financial performance data for the company, so no period-over-period comparisons are available.

• · The private placement is subject to customary closing conditions.
• · Post-closing, the Board will initially have 10 members, including 4 nominated by Purchaser; after regulatory approvals, the Board will reduce to 8 members, including 1 nominated by Purchaser and 1 independent director identified by Purchaser.
• · Purchaser retains director nomination rights based on ownership thresholds: at least 7.5% (2 directors) or between 5.0% and 7.5% (1 director) after the 2027 annual meeting.
• · Purchaser also receives project-level acquisition fees and/or promote incentives for post-closing services, subject to arm's-length terms and approvals.
• · No transactions in the Common Stock were effected by the Reporting Persons in the past 60 days (except as described in Item 3 of Amendment No. 4).

20-07-2026

Dennis J. Wilson and related entities filed Amendment No. 23 to their Schedule 13D, reporting aggregate beneficial ownership of 9,740,710 shares (8.6%) of lululemon athletica inc. as of July 17, 2026. On that date, Low Tide Properties Ltd. sold 164,146 shares under a Master Confirmation with Citibank to provide financial flexibility for unrelated investments, reducing its direct holdings to 389,976 shares. The filing emphasizes that the sale does not reflect a change in the group's investment thesis.

• · The group's ownership structure includes 5,115,961 exchangeable shares paired with special voting stock, which have voting but no economic rights.
• · Dennis J. Wilson directly holds only 3,852 common shares; the bulk of his beneficial ownership is through entities (Anamered: 4,755,217 exchangeable shares; LIPO: 3,401,596 common shares).
• · Following the sale, 164,146 shares remain pledged under the Master Confirmation with Citibank, representing ~0.1446% of outstanding shares.
• · The filing notes that exchangeable shares can be redeemed for common stock plus accrued dividends, and upon exchange the corresponding special voting stock is cancelled.

20-07-2026

Velan Capital and related entities filed an amended Schedule 13D disclosing an aggregate 9.88% beneficial ownership stake in Jasper Therapeutics, Inc. following the company's acquisition of Kira Pharmaceuticals on July 16, 2026. The filing details holdings across multiple funds and individuals, with total beneficial ownership of 3,349,547 shares. Director Vishal Kapoor resigned immediately after the merger effective time, and holds a separate 0.1% stake.

• · The aggregate purchase price for Velan Master's 2,381,915 shares was approximately $23,133,322.
• · Velan Master also owns 1,193,415 warrants acquired in the 2025 Offering.
• · Velan Horizon's 41,152 shares cost approximately $94,855; it also holds 41,152 warrants.
• · Avego Fund's 245,328 shares cost approximately $21,512,500.
• · Vishal Kapoor's 35,013 shares include 4,375 granted upon the Business Combination closing and 30,638 from stock options.
• · Total outstanding shares post-merger: 33,204,811 (28,009,802 pre-merger + 5,195,009 issued in merger).
• · If warrants were not subject to the 9.99% ownership limitation, the group would own 11.4% of outstanding shares.
• · No transactions in the issuer's securities by the reporting persons during the past 60 days.

20-07-2026

Mark N. Tompkins filed a Schedule 13G with the SEC on July 20, 2026, disclosing beneficial ownership of 7,500,000 shares of Margaree Acquisition Corp. common stock, representing 75% of the 10,000,000 shares outstanding as of July 17, 2026. This filing indicates a controlling stake by Tompkins in the blank check company.

• · The filing is a Schedule 13G, indicating passive investment intent (not an activist filing).
• · Tompkins has sole voting power and sole dispositive power over all 7,500,000 shares.
• · Tompkins' address is in Lugano-Paradiso, Switzerland, and he is a Canadian citizen.
• · The issuer is a blank check company (SIC 6770) incorporated in Delaware.

20-07-2026

Lei Wu, founder and CEO of GigaCloud Technology Inc, filed an amended Schedule 13G disclosing beneficial ownership of 7,316,732 Class A Ordinary Shares as of June 30, 2026, representing 20.0% of the outstanding Class A shares. The filing reflects no change in ownership from the prior filing, with Mr. Wu's stake held directly and indirectly through Shan Lao Hu Tong LLC and Ji Xiang Hu Tong Holdings Limited. The ownership percentage is based on 29,630,756 Class A Ordinary Shares outstanding as of April 28, 2026.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(d), indicating passive investment intent.
• · Lei Wu's beneficial ownership includes 5,000 Class B Ordinary Shares, which are convertible at any time into an equal number of Class A Ordinary Shares.
• · The filing date is July 20, 2026, with ownership data as of June 30, 2026.
• · No securities are disposed of or sold by the reporting persons (dispositive power is 0 for all).

20-07-2026

Docebo Inc. announced a substantial issuer bid to repurchase up to $70 million of its common shares at $20.40 per share. Major shareholder Intercap Inc. (controlled by Jason Chapnik, who holds a 64.0% beneficial stake) intends to participate in the offer to maintain its ownership percentage, though its decision remains subject to market conditions. The buyback could increase Intercap's percentage ownership if other shareholders tender more shares.

• · The substantial issuer bid was approved by Docebo's board of directors on July 17, 2026.
• · Intercap's participation is subject to market conditions and other factors; it reserves the right to change its intentions.
• · No other transactions in Docebo securities by the reporting persons during the past 60 days, except for the 2,019 DSU grant to Chapnik.
• · The percentage ownership figures are based on 24,898,022 common shares outstanding as reported by the issuer.

20-07-2026

Aberdeen Group plc and its subsidiary abrdn Inc. filed an amended Schedule 13G disclosing beneficial ownership of 6,769,954 shares of Codexis, Inc. common stock, representing 7.45% of the outstanding shares as of June 30, 2026. The filing indicates passive investment intent, with no change in control purpose.

• · The shares are held by abrdn Inc. as investment advisor on behalf of underlying clients.
• · Aberdeen Group plc is the parent company; abrdn Holdings Limited is the intermediate holding company for abrdn Inc.

20-07-2026

Law Man San Vincent, chairman and major founder of SOLAI Ltd, filed an amended Schedule 13D disclosing increased beneficial ownership. As of July 16, 2026, Mr. Law beneficially owns 178,142,363 Class A Ordinary Shares (9.3% of as-converted shares) and holds 93.9% of total voting power through his holdings of Class A, Class B, Class A Preference, and Class A II Preference shares. The filing also reports open market purchases of 54,275 ADSs for $194,007.37 on July 16, 2026, increasing his ADS holdings from 77,967 to 132,242.

• · Mr. Law's beneficial ownership includes 85,572,963 Class A Ordinary Shares via Good Luck, 132,242 ADSs (representing 92,569,400 Class A Ordinary Shares) directly, 6 Class B Ordinary Shares via Delite, and 65,000 each of Class A Preference and Class A II Preference Shares via Good Luck.
• · The ADS ratio changed from 1:100 to 1:700 effective July 6, 2026.
• · Mr. Law's spouse, Ping Yuan, beneficially owns 10,260,000 Class A Ordinary Shares (via Smart Mega) and 8 Class B Ordinary Shares.
• · Good Luck Capital holds 85,572,963 Class A Ordinary Shares (4.5% of as-converted) and 93.6% voting power.
• · Delite holds 6 Class B Ordinary Shares (0.0% voting power).
• · No Class A Ordinary Shares are issuable to Mr. Law upon exercise of options or vesting of RSUs within 60 days.

20-07-2026

Lincoln Financial Investments Corp and affiliates filed Amendment No. 3 to Schedule 13D, disclosing that as of July 20, 2026, Lincoln National Life Insurance Co. (LNL) directly owns 5,304,989.83 Class I shares (14.83% of the class), and 100% of Class A, Class D, and Class IS shares of Lincoln Bain Capital Total Credit Fund. The filing details recent acquisitions via dividend reinvestment and a working capital purchase, with Lincoln Financial Investments Corp (LFI) deemed beneficial owner of 25,154,976.98 Class I shares (70.33% of the class). No negative or flat performance metrics are reported.

• · LNL acquired Class A shares at $9.76/share, Class D at $9.77/share, Class I at $10.15/share, and Class IS at $9.77/share via dividend reinvestment on July 8, 2026.
• · LFI acquired Class I shares at $10.16/share via working capital purchase on June 16, 2026.
• · The filing amends Items 3, 5(c), 8, 10, 11, and 13 of the initial Schedule 13D.
• · No transactions in Shares were effected by Reporting Persons in the past 60 days other than those described in Item 3.

20-07-2026

The Hewlett Fund LP disclosed a 9.99% beneficial ownership stake in Nuvve Holding Corp. as of July 16, 2026, holding 57,648 shares of common stock. The filing is a Schedule 13G (passive investment) and notes that the fund is contractually restricted from owning more than 9.99% of the company's outstanding shares. Based on 577,064 shares outstanding as of June 30, 2026, the fund's stake represents the maximum allowed under this restriction.

• · The filing is made under Rule 13d-1(c), indicating a passive investment intent.
• · The fund's ownership is capped at 9.99% due to a contractual restriction; full exercise of its securities would exceed this limit.
• · The fund has sole voting and dispositive power over all 57,648 shares.

20-07-2026

Paisley Capital Holdings Corp disclosed a 6.7% beneficial ownership stake in Conexeu Sciences Inc., holding 1,800,000 shares of common stock as of June 30, 2026. The filing was made on Schedule 13G, indicating a passive investment. No changes in ownership or transactions were reported for the period.

• · Filing type is Schedule 13G (passive investment, not activist)
• · Paisley Capital Holdings Corp is organized in the British Virgin Islands and based in Baar, Switzerland
• · No transactions were reported; the 1,800,000 shares represent sole voting and dispositive power
• · The filing date is July 20, 2026, with ownership as of June 30, 2026

20-07-2026

Federated Hermes, Inc., together with related entities and trustees, filed an amended Schedule 13G with the SEC on July 20, 2026, disclosing beneficial ownership of 441,658 common shares of SCYNEXIS INC as of June 30, 2026. This stake represents a 4.03% ownership interest in the pharmaceutical company. All reporting parties expressly disclaim beneficial ownership of the securities under Rule 13d-4, and the filing is routine in nature with no changes to the previously reported position.

20-07-2026

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. filed a Schedule 13G on July 20, 2026, disclosing beneficial ownership of 700,000 Class A Ordinary Shares of Research Alliance Corp IV, representing a 7.7% stake. The filing indicates a passive investment intent, with no plans to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Each Reporting Person disclaims beneficial ownership except to the extent of their pecuniary interest.
• · The shares are held directly by the Master Fund; Perceptive Advisors and Mr. Edelman may be deemed beneficial owners through their roles.
• · No transactions in the securities were reported by the Reporting Persons in the past 60 days.

20-07-2026

RA Capital Management, L.P. and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 4,344,772 shares of Agenus Inc. common stock, representing 9.9% of the outstanding shares as of July 13, 2026. The filing also details the Fund's holdings of pre-funded warrants exercisable for up to 6,775,067 shares, Series A warrants for up to 6,218,905 shares, and Series B warrants for up to 9,940,357 shares, all subject to beneficial ownership blockers that cap the Reporting Persons' ownership at 9.99%. The Reporting Persons disclaim beneficial ownership beyond the reported shares and state the securities were not acquired to change or influence control of the issuer.

• · The Fund directly holds 4,122,000 shares of common stock in addition to the warrants.
• · The beneficial ownership percentage is based on 41,642,431 shares outstanding as of May 7, 2026, plus 1,626,015 shares issued in a private placement that closed on July 15, 2026.
• · The Fund has delegated to RA Capital the sole power to vote and dispose of all securities, and cannot revoke that delegation on less than 61 days' notice.
• · The Reporting Persons expressly disclaim status as a 'group' for purposes of this Schedule 13G.

20-07-2026

Lynx1 Capital Management LP and Weston Nichols filed a Schedule 13G disclosing beneficial ownership of 1,390,611 shares of Precision BioSciences Inc. common stock, representing a 5.4% stake based on 25,802,247 shares outstanding as of April 30, 2026. The filing indicates a passive investment intent under Rule 13d-1(c), with no intention to change or influence control of the company.

• · The filing is made pursuant to Rule 13d-1(c), indicating a passive investor status.
• · The shares are directly held by Lynx1 Master Fund LP, with Lynx1 Capital Management LP as investment manager.
• · Weston Nichols is the sole member of Lynx1 Capital Management GP LLC, the general partner of the investment manager.
• · The filing date is July 20, 2026, with the event date of beneficial ownership as July 13, 2026.

20-07-2026

GAMCO Investors, Inc. et al. filed a Schedule 13D/A disclosing aggregate beneficial ownership of 2,634,758 shares (20.92%) of LGL Group Inc. as of July 16, 2026, following the completion of the issuer's rights offering. The filing shows a significant increase in holdings, with Mario Gabelli personally owning 1,292,596 shares (10.26%) and GGCP, Inc. owning 1,144,648 shares (9.09%). The group spent approximately $10.4 million to acquire additional shares in the rights offering, with Mario Gabelli contributing $5.1 million of private funds.

• · The filing is an amendment to Schedule 13D, not an initial filing, indicating a change in ownership.
• · All transactions on July 16, 2026 were at a price of $6.90 per share, resulting from the completion of the issuer's subscription rights offering.
• · The reporting persons filed the long-form Schedule 13D even though they may be eligible for the short-form Schedule 13G, to ensure compliance with reporting obligations when communicating with management.
• · Gabelli Funds has sole dispositive and voting power over shares held by the Funds, subject to a 25% aggregate voting interest cap, with special circumstances allowing the Proxy Voting Committee to exercise full voting power.
• · No single investment advisory client or partnership has an interest relating to more than 5% of the securities, except as noted.

20-07-2026

Rich Huang and affiliated entities (RichRich Capital LLC, Huang Capital Inc.) filed a Schedule 13G disclosing aggregate beneficial ownership of 5.13% of Churchill Capital Corp XI's Class A Ordinary Shares as of July 13, 2026. Huang Capital Inc. holds 3.17% (1,330,008 shares), RichRich Capital holds less than 1% (179,026 shares), and Mr. Huang individually and via IRAs holds 641,143 shares. The filing is a passive investment disclosure under Rule 13d-1(c), with no intent to change or influence control of the issuer.

• · The filing is a Schedule 13G (passive investment), not a 13D (activist), indicating no intent to influence control.
• · Rich Huang disclaims beneficial ownership of shares held by RichRich Capital and Huang Capital.
• · Total outstanding shares as of May 13, 2026: 41,900,000 Class A Ordinary Shares.
• · Rich Huang individually holds 329,331 shares; his IRA accounts hold 311,812 shares.

20-07-2026

Caddis Holdings, LP and its manager Perry Griffin filed a Schedule 13G (converting from a prior Schedule 13D) disclosing beneficial ownership of 52,256,833 shares of Fermi Inc. common stock, representing 8.2% of the 637,574,239 shares outstanding as of May 11, 2026. The filing indicates a passive investment intent under Rule 13d-1(d), with no change in the number of shares held compared to the prior 13D filing.

• · The filing converts a prior Schedule 13D to Schedule 13G under Rule 13d-1(d), indicating a passive investment intent.
• · Perry Griffin is a manager of Caddis Capital, LLC, the general partner of Caddis Holdings, LP, and may be deemed to beneficially own the shares held by Caddis Holdings, LP.
• · Perry Griffin disclaims beneficial ownership except to the extent of his pecuniary interest.
• · The filing includes a Joint Filing Agreement under Rule 13d-1(k) dated May 15, 2026.

20-07-2026

Wentworth Funding LLC filed an amended Schedule 13G/A with the SEC on July 20, 2026, disclosing beneficial ownership of 894,977 shares of Binah Capital Group, Inc. common stock as of June 30, 2026, representing 5.3% of the outstanding shares. This includes 233,818 shares underlying currently exercisable warrants at $11.50 per share. The filing indicates passive investment intent with no control-seeking purpose.

• · Warrant exercise price is $11.50 per share.
• · Percentage calculation includes the 233,818 warrant shares in the denominator.
• · The filing is made under Rule 13d-1(c), indicating passive investor status.
• · Wentworth Funding LLC is a Delaware limited liability company.

20-07-2026

Conversant Capital LLC and related entities filed a Schedule 13G disclosing beneficial ownership of 5,387,220 shares of New ERA Energy & Digital, Inc. (NUAIW) common stock, representing a 5.3% stake as of July 13, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), with no intent to change or influence control of the issuer. The reporting persons include Conversant Opportunity Master Fund LP, Conversant GP Holdings LLC, Conversant Capital LLC, and Michael Simanovsky.

• · The filing is made under Rule 13d-1(c), indicating a passive investment intent.
• · The reporting persons disclaim membership in a group and are filing jointly under Rule 13d-1(k)(1).
• · The company changed its name from New Era Helium Inc. on December 9, 2024, and from Roth CH V Holdings, Inc. on June 25, 2024.
• · The principal business address of the reporting persons is 25 Deforest Ave., Summit, NJ 07901.

20-07-2026

NVIDIA Corporation disclosed beneficial ownership of 22,256,412 Class A ordinary shares of Nebius Group N.V. (formerly Yandex N.V.), representing 9.3% of the outstanding shares, as of July 13, 2026. The position consists of 1,190,476 shares previously reported and 21,065,936 shares issuable upon exercise of a pre-funded warrant acquired on March 11, 2026. However, NVIDIA is prohibited from exercising the warrant or selling the underlying shares until September 11, 2026, and the filing certifies the securities were not acquired to change or influence control of the issuer.

• · The warrant was acquired on March 11, 2026 pursuant to a Securities Purchase Agreement between NVIDIA and Nebius Group N.V.
• · NVIDIA is prohibited from exercising the warrant prior to September 11, 2026 and from selling the underlying shares before that date.
• · The filing is made under Rule 13d-1(c) (passive investor exemption).
• · NVIDIA certifies the securities were not acquired to change or influence control of the issuer.

20-07-2026

Kong Lingtao filed an amended Schedule 13D with the SEC on July 20, 2026, disclosing that on July 15, 2026, he acquired 100,000 Series A Preferred Shares of Ridgetech Inc. (formerly China Jo-Jo Drugstores), each convertible into one ordinary share. Following the acquisition and a 1-for-150 reverse stock split effective April 7, 2026, Kong beneficially owns 114,834 ordinary shares (including shares issuable upon conversion), representing 3.2% of the outstanding shares. The filing shows Kong's continued investment in the company but notes no change in his ownership percentage from the prior filing, as the increase in shares from the preferred conversion appears offset by the reverse split and other share count adjustments.

• · Ridgetech Inc. underwent a 1-for-150 reverse stock split effective April 7, 2026.
• · Kong Lingtao's prior beneficial ownership was 14,834 ordinary shares after the reverse split and before acquiring the preferred shares.
• · Kong Lingtao has not disposed of or acquired any ordinary shares since Amendment No. 1 filed on December 1, 2025.
• · The company's former names included China Jo-Jo Drugstores, Inc. and China Jo-Jo Drugstores Holdings, Inc.

20-07-2026

ReposiTrak, Inc. filed a Schedule 13D disclosing beneficial ownership of 8,900,406 shares of SPAR Group, Inc. common stock, representing 31.4% of outstanding shares. The stake was built through a combination of open-market purchases (4,709,837 shares for ~$3.3M on July 1, 2026) and a share-for-services exchange (3,190,569 shares valued at $2,325,000 under a March 2026 Services Agreement). ReposiTrak states the investment is for investment purposes and not to change or influence control, though its large stake could be deemed to have that effect.

• · ReposiTrak's business is a B2B e-commerce, compliance & traceability, and supply chain management SaaS platform.
• · The Services Agreement between ReposiTrak and SPAR Group is dated March 13, 2026, with a one-year term.
• · ReposiTrak may acquire additional shares or dispose of its investment depending on market conditions.
• · No criminal convictions or securities-related civil proceedings involving ReposiTrak in the last five years.

20-07-2026

Millennium Management LLC, together with Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G/A disclosing beneficial ownership of 2,374,296 shares of MacroGenics Inc. common stock as of June 30, 2026, representing 3.7% of the outstanding shares. The filing indicates a passive investment intent, with no aim to change or influence control of the issuer.

• · The filing is an amendment (SC 13G/A) to a prior Schedule 13G.
• · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers.
• · The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.
• · A Joint Filing Agreement dated July 17, 2026 was executed among the reporting persons.

20-07-2026

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G disclosing beneficial ownership of 6,036,999 shares of Perspective Therapeutics, Inc. common stock, representing 5.3% of the outstanding shares as of July 13, 2026. The filing indicates passive investment intent under Rule 13d-1(c).

• · The filing is a Schedule 13G (passive investment) under Rule 13d-1(c).
• · The reporting persons disclaim beneficial ownership of securities held by entities under their control.
• · The filing includes a joint filing agreement among the reporting persons.

20-07-2026

Fairmount Funds Management LLC and its affiliates (Fairmount Healthcare Fund II L.P., Peter Harwin, Tomas Kiselak) filed an amended Schedule 13D disclosing aggregate beneficial ownership of 6,593,385 ordinary shares of Crescent Biopharma, Inc., representing approximately 16.5% of outstanding shares. On July 16, 2026, Fund II purchased 853,450 ordinary shares and pre-funded warrants for 525,897 shares in an underwritten public offering for $20,000,005.60. The filing also notes a 60-day lock-up agreement restricting share sales and that Peter Harwin's stock options for 9,023 shares vested on June 2, 2026.

• · The beneficial ownership limitation for pre-funded warrants is 9.99% of outstanding ordinary shares; for Series A Preferred Shares it is 19.99%, which will automatically reduce to 9.99% when Fairmount and affiliates own 9.0% or less of ordinary shares.
• · Peter Harwin holds options for the benefit of Fairmount-managed funds and disclaims beneficial ownership of the option and underlying common stock.
• · The lock-up agreement with Jefferies LLC and TD Securities (USA) LLC restricts share sales for 60 days following the final prospectus supplement date.
• · The pre-funded warrants have no expiration date and are immediately exercisable at $0.001 per share.
• · The filing amends a Schedule 13D originally filed on June 23, 2025, and previously amended on December 8, 2025.

20-07-2026

CVI Investments, Inc. and its investment manager Heights Capital Management, Inc. filed a Schedule 13G disclosing beneficial ownership of 1,556,081 shares of CalciMedica, Inc. common stock, representing 5.1% of the outstanding shares as of June 23, 2026. The filing is a routine passive ownership disclosure under Rule 13d-1(c), indicating the holder does not intend to influence control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating a passive investor status.
• · Heights Capital Management, Inc. serves as investment manager to CVI Investments, Inc. and may be deemed to beneficially own the same shares.
• · Both reporting persons disclaim beneficial ownership except for pecuniary interest.
• · The company issued 14,938,370 shares in a private placement after the May 6, 2026 reporting date, which would dilute the percentage ownership shown.

20-07-2026

N.A.GLOBAL. CO. LTD. and its sole director, Chong Chow Lee, filed an amended Schedule 13G disclosing beneficial ownership of 2,094,516 ordinary shares (4.90%) of TOYO Co., Ltd as of June 30, 2026. The filing notes that NA Global sold 74,251 shares between February and March 2026 and an additional 377,320 shares between May and June 2026, reducing its stake. Additionally, 721,909 shares have been pledged as collateral under multiple loan agreements, with the lender lacking voting or dispositive power absent a default.

• · The filing is an amendment to Schedule 13G, indicating a change in ownership or other required update.
• · NA Global sold a total of 451,571 ordinary shares in two tranches during 2026, reducing its holdings.
• · The pledged shares (721,909) are excluded from beneficial ownership calculations but are deemed beneficially owned by the lender under SEC rules.
• · The filing certifies that the securities were not acquired to change or influence control of the issuer.

20-07-2026

Millennium Management LLC, together with Millennium Group Management LLC and Israel A. Englander, filed an amended Schedule 13G disclosing beneficial ownership of 3,375,834 shares of Phathom Pharmaceuticals, Inc. common stock, representing 4.2% of the outstanding shares as of June 30, 2026. The filing is a routine passive ownership disclosure under Rule 13d-1(c) and does not indicate any change in control intent.

• · The filing is an amendment to a prior Schedule 13G (SC 13G/A), indicating an update to the previously reported ownership.
• · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Israel A. Englander.
• · The filers certify that the securities were not acquired with the purpose or effect of changing or influencing control of the issuer.

20-07-2026

MD Ehsan Khan filed a Schedule 13D/A with the SEC on July 20, 2026, reporting that he sold all 38,500 shares of Boxlight Corp (BOXL) Class A Common Stock on June 30, 2026, reducing his beneficial ownership to 0 shares (0%). The sale was executed through Charles Schwab using personal funds, and the reporting person has no further plans or proposals with respect to the issuer.

• · The sale occurred on June 30, 2026.
• · The filing is an amendment (Schedule 13D/A) to report the complete disposition of shares.
• · The reporting person used personal funds to acquire the securities originally.
• · No contracts, arrangements, understandings, or relationships exist with respect to the issuer's securities.

20-07-2026

Peter M. Hecht filed an amended Schedule 13D with the SEC on July 20, 2026, reporting beneficial ownership of 910,240 shares of Cyclerion Therapeutics common stock, representing 19.4% of the outstanding shares. The amendment reflects the forfeiture of options to purchase 110,984 shares and the conversion of 351,037 shares of Series A Convertible Preferred Stock into common stock on July 16, 2026. No transactions in common stock were effected during the past 60 days.

• · The amendment is the 8th amendment to the original Schedule 13D filed on May 14, 2021.
• · The conversion of Preferred Stock into Common Stock occurred on July 16, 2026 at the election of the Reporting Person.
• · No transactions in common stock were effected during the past 60 days.

20-07-2026

Murchinson Ltd., a 9.0% shareholder in Nano Dimension Ltd., entered into a settlement agreement on July 17, 2026, ending a proxy fight. Under the deal, four departing directors resigned and three new directors (Pinchos (Paul) Fruchthandler, Moshe Rozenbaum, Eliezer Eli Tarlow) were appointed to the board. Murchinson withdrew its demand for an extraordinary general meeting, and the parties agreed to mutual releases and non-disparagement. However, the settlement came after Murchinson had sold a significant number of shares in late June at prices around $1.32-$1.40, and then repurchased some shares on July 20 at $1.55, while also selling additional shares at $1.53, indicating mixed trading activity.

• · Murchinson's aggregate beneficial ownership was approximately 9.0% of Ordinary Shares as of July 17, 2026.
• · The settlement resulted in the resignation of four directors (Robert Pons, David Stehlin, Dr. Joshua Rosensweig, Andrew Sriubas) and the appointment of three new directors (Pinchos (Paul) Fruchthandler, Moshe Rozenbaum, Eliezer Eli Tarlow).
• · The departing directors forfeited all unvested RSUs and received no severance.
• · Murchinson withdrew its demand for an EGM that had been scheduled for July 31, 2026.
• · Between June 24-26, 2026, Murchinson-related entities sold a total of approximately 1,229,587 ADS at prices ranging from $1.3229 to $1.4026.
• · On July 20, 2026, Murchinson-related entities purchased 150,000 ADS at $1.5523 and sold 1,000,000 ADS at $1.5300.
• · The aggregate purchase price for Nomis Bay's 5,148,731 shares was approximately $14,705,420.
• · The aggregate purchase price for BPY's 3,419,407 shares was approximately $9,785,746.
• · The aggregate purchase price for the Managed Positions' 8,568,138 shares was approximately $24,491,023.

20-07-2026

Achillefs Konstantakopoulos and Costamare Shipping Services Ltd. filed a Schedule 13D disclosing a combined 20.5% beneficial ownership stake in Costamare Bulkers Holdings Ltd (CMDB), representing 4,979,706 shares. The filing details ongoing open-market purchases by Mr. Konstantakopoulos, including 13 transactions in the 60 days prior to the filing at prices ranging from $17.06 to $20.00 per share, and a Rule 10b5-1 plan to acquire up to 500,000 additional shares. The reporting persons state they hold the shares for investment purposes and may increase or decrease their position depending on market conditions.

• · The 20.5% stake was acquired primarily through a pro-rata distribution from Costamare Inc. (CMRE) on May 6, 2025, where CMDB shareholders received 1 share for every 5 CMRE shares held.
• · Mr. Konstantakopoulos has been actively accumulating shares in the open market, with 13 purchases totaling 242,200 shares between June 22 and July 17, 2026, at weighted-average prices from $17.34 to $19.92.
• · The most recent purchase (July 17, 2026) was for 24,177 shares at a weighted-average price of $19.09.
• · Costamare Shipping Services Ltd. receives quarterly share payments (60,509 shares each) under a service agreement with the issuer's vessel-owning subsidiaries.
• · The reporting persons reserve the right to change their plans and may engage legal/financial advisors to evaluate strategic alternatives regarding their holdings.

20-07-2026

Lee Seng Chi filed an amended Schedule 13D with the SEC on July 20, 2026, disclosing beneficial ownership of 1,665,060 Class A shares (on an as-converted basis) of Founder Group Ltd (FGL), representing 6.24% of the company's outstanding shares. The filing reveals that on June 11, 2026, Lee received a grant of 30,000 Class B shares as bonus payments for successfully procuring contracts for multiple large-scale solar photovoltaic plants in Malaysia. The filing also notes a 100-for-1 reverse stock split implemented on February 10, 2026, which reduced Lee's holdings to 26,080 Class A shares and 51,949 Class B shares prior to the bonus grant.

• · The Class B shares carry 20 votes per share, while Class A shares carry 1 vote per share, giving Lee Seng Chi significant voting power disproportionate to his economic stake.
• · The reverse stock split was 100-for-1, effective February 10, 2026.
• · The bonus grant of 30,000 Class B shares was awarded for successful procurement of contracts for multiple large-scale solar photovoltaic plants in Malaysia.

20-07-2026

Ophir Asset Management Pty Ltd filed a Schedule 13G with the SEC on July 20, 2026, disclosing beneficial ownership of 3,599,006 shares of ITG, Inc./DE/ Class A Common Stock, representing 7.9% of the 45,862,242 shares outstanding. The filing indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business.
• · Ophir Asset Management Pty Ltd is based in Sydney, Australia, and serves as the General Partner for the two funds.
• · The issuer's business address is 2400 E Commercial Blvd, Ste. 1000, Fort Lauderdale, FL 33308.

20-07-2026

Aberdeen Group plc and its subsidiary abrdn Inc. filed a Schedule 13G/A disclosing beneficial ownership of 2,848,117 ordinary shares of uniQure N.V., representing 4.52% of the outstanding shares as of June 30, 2026. The filing indicates a decrease from the prior 5%+ threshold, as abrdn Inc. now holds less than 5% on behalf of its underlying clients. The shares are held in the ordinary course of business and not for changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) indicating a change from a prior filing where the group likely held 5% or more.
• · abrdn Inc. beneficially owns the shares on behalf of underlying clients and certifies it holds less than 5% of the outstanding shares of the security class.
• · The shares are held in the ordinary course of business and not for changing or influencing control of the issuer.

20-07-2026

Jialin (Gavin) Qu filed a Schedule 13G with the SEC on July 20, 2026, disclosing beneficial ownership of 476,490 common shares of Sphere 3D Corp., representing 6.2% of the outstanding shares. The shares were acquired in exchange for his holdings in Cathedra Bitcoin Inc. following Sphere 3D's acquisition of Cathedra Bitcoin. The filing is a passive investment disclosure (Rule 13d-1(c)) and does not indicate any intent to change or influence control of the issuer.

• · Jialin Qu acquired the shares in exchange for his Cathedra Bitcoin Inc. shares as part of Sphere 3D's acquisition of Cathedra Bitcoin.
• · Qu holds 5,564 shares directly and 470,926 shares through the Togetsu Trust, for which he serves as trustee with voting and dispositive control.
• · The beneficiaries of the Togetsu Trust are family members of Qu, and Qu disclaims pecuniary interest in the trust-held shares.
• · The filing is made under Rule 13d-1(c), indicating a passive investment intent.

20-07-2026

SEG JETS SPV I, LLC filed a Schedule 13G with the SEC on July 20, 2026, disclosing beneficial ownership of 1,065,620 shares of Catheter Precision, Inc. (VTAK) common stock, representing 9.79% of the 10,880,868 shares outstanding. The filing indicates a passive investment intent under Rule 13d-1(c), with no intention to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating a passive investment.
• · SEG JETS SPV I, LLC is a Delaware limited liability company with a business address at 135 Sycamore Drive, Roslyn, NY 11576.
• · The issuer's common stock has a par value of $0.0001 per share.
• · The filing date is July 20, 2026, and the date of event which requires the statement is also July 20, 2026.

20-07-2026

Franklin Resources Inc. and its wholly-owned subsidiary BSP Fund HoldCo (Debt Strategy) L.P. disclosed a 54.5% beneficial ownership stake in Franklin BSP Lending Fund via 75,000 Class I shares acquired on January 29, 2026, for $750,000. The filing is an amendment to Schedule 13D, with no recent transactions in the past 60 days and no plans for further acquisitions or dispositions.

• · The acquisition was made using HoldCo's working capital to support the Issuer's investment strategy.
• · Charles B. Johnson and Rupert H. Johnson, Jr. disclaim any pecuniary interest in the shares and are not deemed beneficial owners.
• · No transactions in the past 60 days and no current plans for further acquisitions or dispositions.

20-07-2026

Hingham Institution for Savings and its wholly owned subsidiary, Hingham Unpledged Securities Corporation, filed a Schedule 13G disclosing beneficial ownership of 334,137 shares of Chain Bridge Bancorp Inc Class A common stock, representing a 9.9% stake. The filing indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(b), indicating passive investment intent.
• · Hingham Institution for Savings is organized under Massachusetts law; its subsidiary Hingham Unpledged Securities Corporation is also a Massachusetts entity.
• · The beneficial ownership includes 334,137 shares with sole voting and dispositive power, and no shared power.
• · The filing date is July 20, 2026, with the event date as of June 30, 2026.

20-07-2026

Alejandro Gonzalez filed a Schedule 13G/A with the SEC on July 20, 2026, disclosing beneficial ownership of 30,061,917 ordinary shares of REZOLVE AI PLC, representing 7.5% of the outstanding shares as of July 14, 2026. The filing indicates a passive investment intent under Rule 13d-1(c).

• · The filing is an amendment (Schedule 13G/A) to a prior Schedule 13G.
• · The shares are held directly by Alejandro Gonzalez with sole voting and dispositive power.
• · The filing certifies that the securities were not acquired to change or influence control of the issuer.

20-07-2026

Mangrove Partners IM, LLC and its President Nathaniel August disclosed beneficial ownership of 239,875 Class A ordinary shares of ChampionsGate Acquisition Corp, representing 2.78% of the 8,617,125 shares outstanding as of June 30, 2026. The shares are held indirectly through The Mangrove Partners Master Fund, Ltd., and the filing is a routine Schedule 13G/A amendment under Rule 13d-1(b), indicating passive investment intent. No change in ownership from the prior filing is reported, and the filers disclaim beneficial ownership of shares not directly held.

• · The filing is an amendment to Schedule 13G, not an initial filing.
• · The shares are held directly by The Mangrove Partners Master Fund, Ltd., a Cayman Islands exempted company.
• · Mangrove Partners IM, LLC serves as investment manager of the Master Fund.
• · The filers certify the securities were acquired and are held in the ordinary course of business, not for changing or influencing control.
• · No change in ownership from the prior filing is indicated.

20-07-2026

Mangrove Partners IM, LLC and its President Nathaniel August disclosed beneficial ownership of 1,055,000 Class A ordinary shares of Clearthink 1 Acquisition Corp. (CTAA) as of June 30, 2026, representing an 8.43% stake. The shares are held indirectly through The Mangrove Partners Master Fund, Ltd., for which Mangrove Partners serves as investment manager. The filing is a routine Schedule 13G under Rule 13d-1(b), indicating passive investment intent with no aim to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(b), indicating the shares were acquired and are held in the ordinary course of business, not for changing or influencing control.
• · Both Mangrove Partners IM, LLC and Nathaniel August disclaim beneficial ownership of shares not directly owned by them.
• · The issuer's total outstanding shares (12,515,000) are based on the 10-Q filed with the SEC on May 15, 2026.

20-07-2026

L.I.A. Pure Capital Ltd. and its affiliates filed an amended Schedule 13D with the SEC on July 20, 2026, reporting that they have increased their beneficial ownership in Evogene Ltd. to approximately 16.81% of the outstanding share capital. The increase resulted from Pure Capital's additional purchases of 202,000 American Depositary Shares (ADSs) between July 10 and July 17, 2026, at prices ranging from $0.499 to $0.635 per ADS. The filing also notes that the total number of ordinary shares outstanding is not publicly disclosed, so the actual percentage ownership may be lower than reported.

• · The additional 202,000 ADSs were acquired in three transactions: 40,000 ADSs at $0.499 on July 10, 57,354 ADSs at $0.591 on July 16, and 104,646 ADSs at $0.635 on July 17, 2026.
• · The reporting persons share voting power over 2,172,000 ADSs and 56,100 ordinary shares pursuant to an oral voting agreement.
• · The filing states that the total number of ordinary shares outstanding was not disclosed by the issuer, so the reported percentage ownership may be lower than 16.81%.